Skip to main content
logo
Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
9.97
-0.10 (-0.99%)
At close: Jul 29, 2026, 4:00 PM EDT
9.95
-0.02 (-0.25%)
After-hours: Jul 29, 2026, 4:27 PM EDT

Keros Therapeutics Revenue

Keros Therapeutics had revenue of $367.00K in the quarter ending March 31, 2026, a decrease of -99.83%. This brings the company's revenue in the last twelve months to $33.18M, down -84.55% year-over-year. In the year 2025, Keros Therapeutics had annual revenue of $244.06M with 6,774.96% growth.

Revenue (ttm)
$33.18M
Revenue Growth
-84.55%
P/S Ratio
5.93
Revenue / Employee
$381,402
Employees
87
Market Cap
197.32M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025244.06M240.51M6,774.96%
Dec 31, 20243.55M3.40M2,250.99%
Dec 31, 2023151.00K--
Dec 31, 2022---
Dec 31, 202120.10M--
Dec 31, 2020---
Dec 31, 201910.00M--
Dec 31, 201810.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Protalix BioTherapeutics76.38M
Cellectis75.11M
Atrium Therapeutics36.68M
MediWound14.48M
Whitehawk Therapeutics7.15M
Entrada Therapeutics5.74M
Revenue Rankings

KROS News

More News